Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
Drive stronger board discussions at organizations with key questions on cyber risk, AI oversight, crisis planning, M&A outlook and tax law changes.
Life sciences companies often overlook SOX in IPO prep. Discover how early action and targeted strategies can strengthen investor confidence.
The DOJ’s updated compliance guidelines require proactive AI risk management. Take steps to ensure your company meets the standards.
J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.
Discover how outsourcing in pharmaceutical manufacturing enhances quality, ensures compliance and mitigates risks in a rapidly evolving industry.
Within the changing landscape of educational technology, schools face new risk factors that affect students, faculty and administrators.
PCI DSS sets the standard for payment card security in higher education detailing compliance levels, reporting requirements and strategies to protect data.
Administrative, physical, and technical safeguards are an essential element of HIPAA security and essential for protecting PHI and ePHI.
Boards and management should examine how traditional and emerging risks, especially generative AI and other new technology, may affect their operations.
1 2 3